BioNTech SE - ADR vs Coursera Inc — how do they compare? BioNTech SE - ADR trades at $92.23 (market cap $23.31B), while Coursera Inc trades at $5.65 (market cap $1.50B). The key difference: BioNTech SE - ADR is far larger — about 15.5× Coursera Inc's market cap, and BioNTech SE - ADR is trading nearer its 52-week high, Coursera Inc nearer its low. Which is the better fit depends on your goals.
| BNTX | COUR | |
|---|---|---|
Market Cap | $23.31B | $1.50B |
Sector | Health | Consumer Staples |
52-Week High | $119.34 | $12.20 |
52-Week Low | $83.89 | $5.09 |
Enterprise Value | $6.60B | $759.54M |
Trailing returns across standard periods
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →Coursera Inc is a global online learning platform that offers anyone, anywhere access to online courses and degrees from world-class universities and companies. It combines content, data, and technology into a single, unified platform that is customizable and extensible to both individual learners and institutions. The platform will contain a catalog of high-quality content and credentials, content developed by leading university and industry partners, data and machine learning drive personalized Learning, effective marketing, and skills Benchmarking and others.
Read more on COUR →